Search
forResearch 10 of 1000+
- Follicular and epidermal alterations in patients treated with ZD1839 (Iressa), an inhibitor of the epidermal growth factor receptor
- Epidermal Growth Factor Receptor Inhibitors: Cutaneous Side Effects and Their Management.
- Skin toxicity induced by chemotherapy or molecular targeted therapy combined with immune checkpoint inhibitors in Asian patients: A literature review by the Japanese Pharmacist-led Oncodermatology Study Team
- Role for the Epidermal Growth Factor Receptor in Chemotherapy-Induced Alopecia
- Cutaneous Side Effects in Non-Small Cell Lung Cancer Patients Treated with Iressa (ZD1839), an Inhibitor of Epidermal Growth Factor
- 3D organotypic skin models recapitulate autoantibody-driven pemphigus pathomechanisms and targeted therapeutic response
- Cutaneous adverse effects of targeted therapies
- Advances in the Management of Cutaneous Toxicities of Targeted Therapies
- Dermatologic Reactions to Targeted Therapy
- Adverse Hair Reactions to New Targeted Therapies for Cancer